世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Thyroid Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4953 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、甲状腺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・甲状腺がん分子診断の市場動向 ・企業の競争状況、市場シェア ・甲状腺がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・甲状腺がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・甲状腺がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・甲状腺がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・甲状腺がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・甲状腺がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・甲状腺がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biomerieux、Mole、Genetronhealth、Berryoncology、Gene+、Annoroad、Topgen、Geneis、Kingmed、Unitedgene） ・結論

A molecular approach for diagnosing thyroid cancer

Market Analysis and Insights: Global Thyroid Cancer Molecular Diagnostics Market
The global Thyroid Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Thyroid Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Thyroid Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Thyroid Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Thyroid Cancer Molecular Diagnostics market.

Global Thyroid Cancer Molecular Diagnostics Scope and Market Size
Thyroid Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Thyroid Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biomerieux
Mole
Genetronhealth
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Kingmed
Unitedgene

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Thyroid Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Thyroid Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Thyroid Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Thyroid Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Thyroid Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Thyroid Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Thyroid Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Thyroid Cancer Molecular Diagnostics Market Trends
2.3.2 Thyroid Cancer Molecular Diagnostics Market Drivers
2.3.3 Thyroid Cancer Molecular Diagnostics Market Challenges
2.3.4 Thyroid Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Thyroid Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Thyroid Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Thyroid Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Thyroid Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Thyroid Cancer Molecular Diagnostics Revenue
3.4 Global Thyroid Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Thyroid Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Cancer Molecular Diagnostics Revenue in 2020
3.5 Thyroid Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Thyroid Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Thyroid Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Thyroid Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Thyroid Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Thyroid Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Thyroid Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Thyroid Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Thyroid Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Thyroid Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Thyroid Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Thyroid Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Thyroid Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Thyroid Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Thyroid Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Thyroid Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Thyroid Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Thyroid Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biomerieux
11.1.1 Biomerieux Company Details
11.1.2 Biomerieux Business Overview
11.1.3 Biomerieux Thyroid Cancer Molecular Diagnostics Introduction
11.1.4 Biomerieux Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Biomerieux Recent Development
11.2 Mole
11.2.1 Mole Company Details
11.2.2 Mole Business Overview
11.2.3 Mole Thyroid Cancer Molecular Diagnostics Introduction
11.2.4 Mole Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Mole Recent Development
11.3 Genetronhealth
11.3.1 Genetronhealth Company Details
11.3.2 Genetronhealth Business Overview
11.3.3 Genetronhealth Thyroid Cancer Molecular Diagnostics Introduction
11.3.4 Genetronhealth Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Genetronhealth Recent Development
11.4 Berryoncology
11.4.1 Berryoncology Company Details
11.4.2 Berryoncology Business Overview
11.4.3 Berryoncology Thyroid Cancer Molecular Diagnostics Introduction
11.4.4 Berryoncology Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Berryoncology Recent Development
11.5 Gene+
11.5.1 Gene+ Company Details
11.5.2 Gene+ Business Overview
11.5.3 Gene+ Thyroid Cancer Molecular Diagnostics Introduction
11.5.4 Gene+ Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Gene+ Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Thyroid Cancer Molecular Diagnostics Introduction
11.6.4 Annoroad Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Annoroad Recent Development
11.7 Topgen
11.7.1 Topgen Company Details
11.7.2 Topgen Business Overview
11.7.3 Topgen Thyroid Cancer Molecular Diagnostics Introduction
11.7.4 Topgen Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Topgen Recent Development
11.8 Geneis
11.8.1 Geneis Company Details
11.8.2 Geneis Business Overview
11.8.3 Geneis Thyroid Cancer Molecular Diagnostics Introduction
11.8.4 Geneis Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Geneis Recent Development
11.9 Kingmed
11.9.1 Kingmed Company Details
11.9.2 Kingmed Business Overview
11.9.3 Kingmed Thyroid Cancer Molecular Diagnostics Introduction
11.9.4 Kingmed Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Kingmed Recent Development
11.10 Unitedgene
11.10.1 Unitedgene Company Details
11.10.2 Unitedgene Business Overview
11.10.3 Unitedgene Thyroid Cancer Molecular Diagnostics Introduction
11.10.4 Unitedgene Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Unitedgene Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Thyroid Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Thyroid Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Thyroid Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Thyroid Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Thyroid Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Thyroid Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Thyroid Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Thyroid Cancer Molecular Diagnostics Market Trends
Table 13. Thyroid Cancer Molecular Diagnostics Market Drivers
Table 14. Thyroid Cancer Molecular Diagnostics Market Challenges
Table 15. Thyroid Cancer Molecular Diagnostics Market Restraints
Table 16. Global Thyroid Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Thyroid Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Thyroid Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thyroid Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Thyroid Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Thyroid Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Thyroid Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Thyroid Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Thyroid Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Thyroid Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Thyroid Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Thyroid Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Thyroid Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Thyroid Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Thyroid Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Biomerieux Company Details
Table 64. Biomerieux Business Overview
Table 65. Biomerieux Thyroid Cancer Molecular Diagnostics Product
Table 66. Biomerieux Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Biomerieux Recent Development
Table 68. Mole Company Details
Table 69. Mole Business Overview
Table 70. Mole Thyroid Cancer Molecular Diagnostics Product
Table 71. Mole Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Mole Recent Development
Table 73. Genetronhealth Company Details
Table 74. Genetronhealth Business Overview
Table 75. Genetronhealth Thyroid Cancer Molecular Diagnostics Product
Table 76. Genetronhealth Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Genetronhealth Recent Development
Table 78. Berryoncology Company Details
Table 79. Berryoncology Business Overview
Table 80. Berryoncology Thyroid Cancer Molecular Diagnostics Product
Table 81. Berryoncology Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Berryoncology Recent Development
Table 83. Gene+ Company Details
Table 84. Gene+ Business Overview
Table 85. Gene+ Thyroid Cancer Molecular Diagnostics Product
Table 86. Gene+ Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Gene+ Recent Development
Table 88. Annoroad Company Details
Table 89. Annoroad Business Overview
Table 90. Annoroad Thyroid Cancer Molecular Diagnostics Product
Table 91. Annoroad Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Annoroad Recent Development
Table 93. Topgen Company Details
Table 94. Topgen Business Overview
Table 95. Topgen Thyroid Cancer Molecular Diagnostics Product
Table 96. Topgen Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Topgen Recent Development
Table 98. Geneis Company Details
Table 99. Geneis Business Overview
Table 100. Geneis Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Geneis Recent Development
Table 102. Kingmed Company Details
Table 103. Kingmed Business Overview
Table 104. Kingmed Thyroid Cancer Molecular Diagnostics Product
Table 105. Kingmed Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Kingmed Recent Development
Table 107. Unitedgene Company Details
Table 108. Unitedgene Business Overview
Table 109. Unitedgene Thyroid Cancer Molecular Diagnostics Product
Table 110. Unitedgene Revenue in Thyroid Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Unitedgene Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thyroid Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Thyroid Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Thyroid Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Thyroid Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Thyroid Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Thyroid Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Thyroid Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Thyroid Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Thyroid Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thyroid Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Thyroid Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Thyroid Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Thyroid Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Thyroid Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Thyroid Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Thyroid Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Thyroid Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Thyroid Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Thyroid Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Thyroid Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Thyroid Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Thyroid Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Thyroid Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Thyroid Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Thyroid Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biomerieux Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Mole Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Genetronhealth Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Berryoncology Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Gene+ Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Annoroad Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Topgen Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Geneis Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Kingmed Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Unitedgene Revenue Growth Rate in Thyroid Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---